Drug capture materials based on genomic DNA-functionalized magnetic nanoparticles. Read more about Drug capture materials based on genomic DNA-functionalized magnetic nanoparticles.
Publisher Correction: FGF signalling controls the specification of hair placode-derived SOX9 positive progenitors to Merkel cells. Read more about Publisher Correction: FGF signalling controls the specification of hair placode-derived SOX9 positive progenitors to Merkel cells.
FGF signalling controls the specification of hair placode-derived SOX9 positive progenitors to Merkel cells. Read more about FGF signalling controls the specification of hair placode-derived SOX9 positive progenitors to Merkel cells.
A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci. Read more about A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci.
Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade. Read more about Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade.
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia. Read more about Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.
Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity. Read more about Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity.
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets. Read more about Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets.
Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma. Read more about Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma.
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance. Read more about Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.
